financetom
Business
financetom
/
Business
/
Citadel to buy power firm Energy Grid in first Japanese acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citadel to buy power firm Energy Grid in first Japanese acquisition
Jun 27, 2024 8:23 PM

TOKYO, June 28 (Reuters) - Citadel will buy Japanese

power firm Energy Grid in its first acquisition in Japan and the

first major U.S. investment in Japan's wholesale energy market

in recent years, billionaire investor Kenneth Griffin's hedge

fund said in a statement.

The privately held Energy Grid provides power price risk

management services to Japanese companies and the deal will give

Citadel direct access to the Japanese power market.

Since Energy Grid's establishment in 2021, the power market

in resource-poor Japan has been volatile due to Russia's

invasion of Ukraine, which precipitated a global energy crisis.

Japan, which imports most of its energy resources, was

already in a precarious position following the March 2011

earthquake and Fukushima nuclear disaster, when many of its

major nuclear power stations were shut down.

The deal will "broaden the delivery of hedging solutions to

Japanese energy producers and consumers", Sebastian Barrack,

head of commodities at Citadel, said.

Energy Grid will expand trading volumes and "offer

longer-term risk management opportunities to more market

participants", said Yohei Jozaki, chief executive officer of

Energy Grid.

The transaction is expected to close in the third quarter of

2024, subject to conditions. The deal size has not been

disclosed.

Miami, Florida-based Citadel manages approximately $63

billion in assets and its flagship fund has gained more than

7.5% so far in 2024, according to a person familiar with the

matter.

(Reporting by Anton Bridge in Tokyo; Editing by Matthew Lewis

and Muralikumar Anantharaman)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dream Unlimited Gets TSX Nod to Renew Share Buyback for Up to 2.3 Million Shares
Dream Unlimited Gets TSX Nod to Renew Share Buyback for Up to 2.3 Million Shares
Sep 21, 2025
08:33 AM EDT, 09/19/2025 (MT Newswires) -- Real estate developer Dream Unlimited ( DRUNF ) said Friday that the TSX accepted the company's notice to renew a normal course issuer bid for one year. Under the NCIB, Dream can purchase for cancellation up to 2,318,152 of its class A subordinate voting shares, or 10% of the company's public float, from...
Advantus Corp. Is Acquiring Perler, Dimensions, Boye, Anker Play, Eureka and Others Adding to Robust Craft and Educational Supply Portfolios
Advantus Corp. Is Acquiring Perler, Dimensions, Boye, Anker Play, Eureka and Others Adding to Robust Craft and Educational Supply Portfolios
Sep 21, 2025
JACKSONVILLE, Fla., Sept. 19, 2025 /PRNewswire/ -- Advantus Corp., a privately-held manufacturer of brands in office, craft, home and recreation, and luggage and tactical segments, today announced it is acquiring several iconic brands including Perler, Dimensions, Boye, Anker Play, and Eureka. The strategic purchase adds additional craft, creative play, needle arts and educational products to Advantus Corp.'s growing roster of brands....
Verrica Says Development Partner Receives Japanese Approval For Ycanth; Shares Rise Pre-Bell
Verrica Says Development Partner Receives Japanese Approval For Ycanth; Shares Rise Pre-Bell
Sep 21, 2025
08:35 AM EDT, 09/19/2025 (MT Newswires) -- Verrica Pharmaceuticals ( VRCA ) said Friday that its development partner, Torii Pharmaceutical, has received approval from the Japanese Ministry of Health, Labour and Welfare for Ycanth, a drug-device combination product for the treatment of molluscum contagiosum. The approval of Ycanth in Japan triggered a one-time $10 million milestone cash payment which Verrica...
Medtronic Gets US FDA Approval for Altaviva Device to Treat Urge Urinary Incontinence
Medtronic Gets US FDA Approval for Altaviva Device to Treat Urge Urinary Incontinence
Sep 21, 2025
08:34 AM EDT, 09/19/2025 (MT Newswires) -- Medtronic ( MDT ) said Friday that it has received US Food and Drug Administration approval for the Altaviva device, a minimally invasive implantable, tibial neuromodulation therapy device, which is inserted near the ankle and designed to treat urge urinary incontinence. The company said the implant procedure does not require sedation or imaging...
Copyright 2023-2026 - www.financetom.com All Rights Reserved